SamanTree Medical is proud to announce being part of the finalists for the Strategis Prize 2018.

Read the press release below (or download the PDF document at the end of the page):

Awarded every year by HEC Espace Entreprise for the last 25 years, the Strategis Award aims at rewarding the best swiss start-up with a CHF 50’000 prize. Innovation, realization and expansion: such are the watchwords of this contest. Participating to such a renowned competition is an incredible opportunity for any young business.

Following the anouncement of the eight semi-finalists, a second meeting was held on the night of March 27th 2018, enabling the jury to finally determine the five finalist start-ups. All of the participating companies had a lot of potential and the various fields of activities – Medtech, crowdfunding, healthTech and robotics – didn’t facilitate the decision.

This second step of the selection process is what renders the Strategis Prize so unique. Indeed, as part of the FIDAG Consulting Award, groups of four students from HEC Lausanne accompanied by partner consultants visited the eight semi-finalist start-up during the month of february. An analysis report was then established as a basis for the jury to select the finalists.

70 start-up at first and only 5 remaining today. Thereafter the names of the five
Strategis Prize finalists:

  • Eyeware
  • Haelixa
  • Inositec
  • Monito
  • SamanTree Medical

A last reunion will be held on April 25th 2018 to determine the laureate of the contest known as the best start-up in Switzerland.

Press release – Strategis Prize 2018-03-28 – EN
Press release – Strategis Prize 2018-03-28 – FR